ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: CML is a rare clonal disorder of HSCs associated with t(9;22) resulting in BCR-ABL1 rearrangement and has an annual incidence of 1 to 2 cases per 100,000 individuals [22].